Application 021663

Type
BLA
Sponsor
FERRING

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
021663Menopurmenotropins351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MENOPURMENOTROPINS (FSH;LH)INJECTABLE;SUBCUTANEOUS75 IU/VIAL;75 IU/VIALNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MenopurMENOTROPINSFerring Pharmaceuticals Inc.22c8db95-c3db-1770-8086-31356fbabe352018-05-31Warnings, Adverse reactionsExact identifier
application number: BLA021663
ndc (product): 55566-7501

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.NDACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.NDACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent
55566-7501MenopurmenotropinsFerring Pharmaceuticals Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
66386APPL2020-03-23
37423SUPPL2020-03-23
28331SUPPL2020-03-23
28330SUPPL2020-03-23
21771ORIG2020-03-23
15941SUPPL2020-03-23
15940SUPPL2020-03-23
15939ORIG2020-03-23
5945SUPPL2020-03-23
5944ORIG2020-03-23